Associations and interactions between lipid profiles, retinopathy and nephropathy in patients with type 1 diabetes: the FinnDiane Study

The aim of this study was to investigate the associations between lipid profiles and retinopathy in the large nationwide FinnDiane Study and to examine interactions and correlations between retinopathy, nephropathy and lipid variables.

[1]  C. Forsblom,et al.  HbA1c variability is associated with an increased risk of retinopathy requiring laser treatment in type 1 diabetes , 2013, Diabetologia.

[2]  T. Wong,et al.  Lipids and diabetic retinopathy , 2012, Expert opinion on biological therapy.

[3]  P. Dodson,et al.  Medical management of diabetic retinopathy: fenofibrate and ACCORD Eye studies , 2011, Eye.

[4]  M. Hermans.  Non-invited Review: Prevention of microvascular diabetic complications by fenofibrate: lessons from FIELD and ACCORD , 2011, Diabetes & vascular disease research.

[5]  J. Shaw,et al.  Serum Apolipoprotein AI and B Are Stronger Biomarkers of Diabetic Retinopathy Than Traditional Lipids , 2011, Diabetes Care.

[6]  Walter T Ambrosius,et al.  Effects of medical therapies on retinopathy progression in type 2 diabetes. , 2010, The New England journal of medicine.

[7]  E. Agardh,et al.  Plasma lipids and plasma lipoproteins in diabetics with and without proliferative retinopathy. , 2009, Acta medica Scandinavica.

[8]  Ronald Klein,et al.  The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XXII the twenty-five-year progression of retinopathy in persons with type 1 diabetes. , 2008, Ophthalmology.

[9]  H. Parving,et al.  Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials , 2008, The Lancet.

[10]  P. Mitchell,et al.  Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial , 2007, The Lancet.

[11]  M. Taskinen,et al.  Relationship between lipid profiles and kidney function in patients with type 1 diabetes , 2007, Diabetologia.

[12]  I. M. Vertkin,et al.  Risk Factors , 2007, Morality and Ethics at War.

[13]  Tom Greene,et al.  Using Standardized Serum Creatinine Values in the Modification of Diet in Renal Disease Study Equation for Estimating Glomerular Filtration Rate , 2006, Annals of Internal Medicine.

[14]  D. Lackland,et al.  Diabetic retinopathy and serum lipoprotein subclasses in the DCCT/EDIC cohort. , 2004, Investigative ophthalmology & visual science.

[15]  C. Forsblom,et al.  Implementation of guidelines for the prevention of diabetic nephropathy. , 2004, Diabetes care.

[16]  A. Albert,et al.  Risk of developing retinopathy in Diabetes Control and Complications Trial type 1 diabetic patients with good or poor metabolic control. , 2001, Diabetes care.

[17]  S. Bandinelli,et al.  Plasma lipids and urinary albumin excretion rate in Type 1 diabetes mellitus: the EURODIAB IDDM Complications Study , 2001, Diabetic medicine : a journal of the British Diabetic Association.

[18]  T. Orchard,et al.  Can clinical factors estimate insulin resistance in type 1 diabetes? , 2000, Diabetes.

[19]  F. Ferris,et al.  Causes of severe visual loss in the early treatment diabetic retinopathy study: ETDRS report no. 24. Early Treatment Diabetic Retinopathy Study Research Group. , 1999, American journal of ophthalmology.

[20]  Philip D. Harvey,et al.  Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 , 1998, BMJ.

[21]  R. Holman,et al.  Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. , 1998 .

[22]  F. Ferris,et al.  Risk factors for high-risk proliferative diabetic retinopathy and severe visual loss: Early Treatment Diabetic Retinopathy Study Report #18. , 1998, Investigative ophthalmology & visual science.

[23]  A. Sjølie,et al.  Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes , 1998, The Lancet.

[24]  Stephen J. Aldington,et al.  Retinopathy and vision loss in insulin-dependent diabetes in Europe. The EURODIAB IDDM Complications Study. , 1997, Ophthalmology.

[25]  The Relationship of Glycemic Exposure (HbA1c) to the Risk of Development and Progression of Retinopathy in the Diabetes Control and Complications Trial , 1995, Diabetes.

[26]  L. Kuller,et al.  Predictors of Microalbuminuria in Individuals with IDDM: Pittsburgh Epidemiology of Diabetes Complications Study , 1993, Diabetes Care.

[27]  H. Chase,et al.  Factors influencing the onset and progression of diabetic retinopathy in subjects with insulin-dependent diabetes mellitus. , 1993, Ophthalmology.

[28]  B. Sinav,et al.  Plasma lipids and lipoproteins in retinopathy of type I (insulin-dependent) diabetic patients. , 1993, Annals of ophthalmology.

[29]  R. Klein,et al.  The epidemiology of diabetes complications study. IV. Correlates of diabetic background and proliferative retinopathy. , 1991, American journal of epidemiology.

[30]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.

[31]  W. Burger,et al.  Risk factors for the development of retinopathy in children and adolescents with Type 1 (insulin-dependent) diabetes mellitus , 2006, Diabetologia.

[32]  T. Sano,et al.  [Diabetic retinopathy]. , 2001, Nihon rinsho. Japanese journal of clinical medicine.

[33]  R. Klein,et al.  THE EPIDEMIOLOGY OF DIABETIC RETINOPATHY: FINDINGS FROM THE WISCONSIN EPIDEMIOLOGIC STUDY OF DIABETIC RETINOPATHY , 1987, International ophthalmology clinics.

[34]  Photocoagulation treatment of proliferative diabetic retinopathy. Clinical application of Diabetic Retinopathy Study (DRS) findings, DRS Report Number 8. The Diabetic Retinopathy Study Research Group. , 1981, Ophthalmology.